Osteoporosis, bone & mineral

Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study

Osteoporos IntPublished Two-sample Mendelian randomization study

Main finding · OP (IVW)Result — go to the resultOdds ratio 0.859 95% CI 0.774–0.953

Authors' conclusion

This study indicated that metformin treatment is significantly associated with a reduction in the risk of OP, fracture and higher LS-BMD, FN-BMD, and eBMD. However, there was no significant association with FA-BMD.

Study context

Population
Summary statistics from genome-wide association studies for metformin treatment and bone outcomes
Comparison
Genetically proxied metformin treatment and osteoporosis (OP), bone mineral density (BMD) and fracture risk
Outcome
Risk of OP
Methodological detailsInverse variance-weighted (IVW) main analysis, sensitivity analyses (Cochran's Q, MR-Egger, leave-one-out, Mendelian randomization pleiotropy residual sum and outlier (MR-PRESSO))
  • IVW main analysis
  • Sensitivity analyses (Cochran's Q, MR-Egger, leave-one-out, MR-PRESSO)

Main finding

OP (IVW)

Odds ratio

0.859

95% CI 0.774–0.953

P = 0.004

Metformin treatment
OR 0.859 (95% CI 0.774–0.953); P = 0.004

As reported in the abstract

Further findings

LS-BMD (IVW)

OR (95% CI)P value
Metformin treatment1.063 (1.023–1.105)P = 0.002

FN-BMD (IVW)

OR (95% CI)P value
Metformin treatment1.034 (1.000–1.069)P = 0.049

Estimated heel BMD (eBMD) (IVW)

OR (95% CI)P value
Metformin treatment1.035 (1.023–1.047)P ≤ 0.001

Fracture (IVW)

OR (95% CI)P value
Metformin treatment0.958 (0.928–0.989)P = 0.008

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study. Osteoporos Int. Published 27 March 2024. doi:10.1007/s00198-023-07013-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.